154 related articles for article (PubMed ID: 31671004)
1. Gabapentin-saccharin co-crystals with enhanced physicochemical properties and
Soliman II; Kandil SM; Abdou EM
Pharm Dev Technol; 2020 Feb; 25(2):227-236. PubMed ID: 31671004
[TBL] [Abstract][Full Text] [Related]
2. Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets.
Tung NT; Tran CS; Nguyen TL; Hoang T; Trinh TD; Nguyen TN
Eur J Pharm Biopharm; 2018 May; 126():187-200. PubMed ID: 28359878
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
4. Co-processed chitin-mannitol as a new excipient for Oro-dispersible tablets.
Daraghmeh N; Chowdhry BZ; Leharne SA; Al Omari MM; Badwan AA
Mar Drugs; 2015 Mar; 13(4):1739-64. PubMed ID: 25830680
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Suspension Formulations of Theophylline Cocrystals With Artificial Sweeteners.
Aitipamula S; Wong ABH; Kanaujia P
J Pharm Sci; 2018 Feb; 107(2):604-611. PubMed ID: 28987500
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of different approaches for preparation of chlorzoxazone orodispersible tablets.
Moqbel HA; ElMeshad AN; El-Nabarawi MA
Drug Dev Ind Pharm; 2017 May; 43(5):742-750. PubMed ID: 27534668
[TBL] [Abstract][Full Text] [Related]
7. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
9. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
Kasliwal N; Negi JS; Jugran V; Jain R
Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form.
Shete AS; Yadav AV; Murthy MS
Drug Dev Ind Pharm; 2013 May; 39(5):716-23. PubMed ID: 22639963
[TBL] [Abstract][Full Text] [Related]
11. Structural Characterization and Pharmaceutical Properties of Three Novel Cocrystals of Ethenzamide With Aliphatic Dicarboxylic Acids.
Kozak A; Marek PH; Pindelska E
J Pharm Sci; 2019 Apr; 108(4):1476-1485. PubMed ID: 30414866
[TBL] [Abstract][Full Text] [Related]
12. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
13. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique.
Labib GS
Drug Des Devel Ther; 2015; 9():5135-46. PubMed ID: 26379426
[TBL] [Abstract][Full Text] [Related]
14. Effects of coformers on phase transformation and release profiles of carbamazepine cocrystals in hydroxypropyl methylcellulose based matrix tablets.
Qiu S; Li M
Int J Pharm; 2015 Feb; 479(1):118-28. PubMed ID: 25542989
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the Pharmaceutical Behavior of Nateglinide by Cocrystallization: Physicochemical Assessment of Cocrystal Formation and Informed Use of Differential Scanning Calorimetry for Its Quantitative Characterization.
Bruni G; Maggi L; Mustarelli P; Sakaj M; Friuli V; Ferrara C; Berbenni V; Girella A; Milanese C; Marini A
J Pharm Sci; 2019 Apr; 108(4):1529-1539. PubMed ID: 30476510
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
Ge Z; Yang M; Wang Y; Shan L; Gao C
Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of metformin oro-dispersible tablets.
Kamboj M; Goyal S; Rakha P; Arora G; Dureja H; Nagpal M
Acta Pol Pharm; 2011; 68(5):717-23. PubMed ID: 21928717
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical and mechanical properties of carbamazepine cocrystals with saccharin.
Rahman Z; Samy R; Sayeed VA; Khan MA
Pharm Dev Technol; 2012; 17(4):457-65. PubMed ID: 21265708
[TBL] [Abstract][Full Text] [Related]
19. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation.
Gao Y; Zu H; Zhang J
J Pharm Pharmacol; 2011 Apr; 63(4):483-90. PubMed ID: 21401599
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.
Panzade P; Shendarkar G; Shaikh S; Balmukund Rathi P
Adv Pharm Bull; 2017 Sep; 7(3):399-408. PubMed ID: 29071222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
